COMMUNIQUÉS West-GlobeNewswire

-
SS Innovations’ SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement
12/03/2024 -
Galectin Therapeutics Expands Clinical Team with the Appointment of Khurram Jamil, M.D. as Vice President, Clinical Development
12/03/2024 -
X4 Pharmaceuticals to Report Fourth-Quarter and Full Year 2023 Financial Results and Host a Conference Call and Webcast on March 21, 2024
12/03/2024 -
Spectral AI Announces New US Government Contract to Further Accelerate the Development of the Handheld Version of DeepView™ Wound Imaging System
12/03/2024 -
Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines
12/03/2024 -
NewAmsterdam Pharma Doses First Patient in Phase 3 TANDEM Clinical Trial Evaluating Fixed-Dose Combination of Obicetrapib and Ezetimibe in Patients with HeFH and/or ASCVD
12/03/2024 -
89bio Initiates Phase 3 ENLIGHTEN-Fibrosis Trial of Pegozafermin in Non-Cirrhotic Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Fibrosis
12/03/2024 -
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
12/03/2024 -
Aileron Therapeutics Announces CEO Transition
12/03/2024 -
Immuneering Appoints Thomas J. Schall, Ph.D. to its Board of Directors
12/03/2024 -
New Post Hoc Analysis of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment in Patients With Type 1 Diabetes and Chronic Kidney Disease
12/03/2024 -
KVA12123 Clears Additional Cohorts in Monotherapy and in Combination Therapy Arms in the Phase 1/2 VISTA-101 Clinical Trial; Initial Clinical Response Data Reported
12/03/2024 -
Tempest Presents New Data at the SITC 2024 Spring Scientific Meeting Supporting Potent Anti-tumor Activity of TPST-1120 in Multiple Cancer Types
12/03/2024 -
Immunovant Awarded U.S. Patent for IMVT-1402
12/03/2024 -
ARECOR AND TRx BIOSCIENCES ESTABLISH RESEARCH COLLABORATION TO DEVELOP ORAL GLP-1 WITH ENHANCED BIOAVAILABILITY
12/03/2024 -
SIGA Declares Special Cash Dividend of $0.60 Per Share
12/03/2024 -
Southern California Clinic uses MedMatrix AI Market Expander to Launch Opening of New Clinic Locations
12/03/2024 -
Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis
12/03/2024 -
CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
12/03/2024
Pages